What are esophageal cancer?

At present, targeted drugs for esophageal cancer are mainly Nimotuzumab, which is a targeted drug used more clinically. However, Nimotuzumab is generally recommended to be used in combination with chemotherapy drugs. It is not recommended to use Nimotuzumab alone. Moreover, its cost is relatively expensive. At this stage, it is not included in the medical insurance policy. Other targeted drugs for esophageal cancer are relatively few, unlike many targeted drugs for lung cancer.